DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRIN
- 1 December 1979
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 314 (8154), 1213-1216
- https://doi.org/10.1016/s0140-6736(79)92334-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- ASPIRIN: A PARADOXICAL EFFECT ON BLEEDING-TIMEThe Lancet, 1978
- Inhibition of platelet prostaglandin synthetase by oral aspirin.Journal of Clinical Investigation, 1978
- Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandinBiochemical and Biophysical Research Communications, 1977
- Bioassay by cascade superfusion using a highly sensitive laminar flow techniqueJournal of Pharmacy and Pharmacology, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- A laminar flow superfusion technique with much increased sensitivity for the detection of smooth muscle-stimulating substancesEuropean Journal of Pharmacology, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.Journal of Clinical Investigation, 1975
- Acetylation of prostaglandin synthase by aspirin.Proceedings of the National Academy of Sciences, 1975